Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2026-02-21 @ 9:24 PM
Study NCT ID:
NCT03618056
Status:
COMPLETED
Last Update Posted:
2022-02-07
First Post:
2018-08-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-17
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-01
First Submit QC Date:
None
Study First Post Date:
2018-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-10-13
Results First Submit QC Date:
None
Results First Post Date:
2021-12-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-31
Last Update Post Date:
2022-02-07
Last Update Post Date Type:
ACTUAL